Literature DB >> 9680051

Diagnosing attention-deficit/hyperactivity disorder in children.

L L Greenhill1.   

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is a heterogeneous behavioral disorder of uncertain etiology that is always evident first in childhood. The correct diagnosis of the ADHD patient thus requires familiarity with how the diagnosis should be established across the life span. This article provides a description of the DSM-IV syndrome of ADHD, information on prevalence, and an overview of standard methods used in office practice to diagnose ADHD in children. These practice parameters will be examined in the light of the practitioner's current concerns about the validity of the diagnosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9680051

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  10 in total

1.  Cardiac risk assessment before the use of stimulant medications in children and youth.

Authors:  S A Bélanger; A E Warren; R M Hamilton; C Gray; R M Gow; S Sanatani; J M Côté; J Lougheed Frcpc; J Leblanc; S Martin; B Miles; C Mitchell; D A Gorman; M Weiss; R Schachar
Journal:  Paediatr Child Health       Date:  2009-11       Impact factor: 2.253

2.  Diagnosing and managing complicated ADHD.

Authors:  Robert L Findling; L Eugene Arnold; Laurence L Greenhill; Christopher J Kratochvil; James J McGough
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

3.  Homocystinuria: Challenges in diagnosis and management.

Authors:  J Garland; A Prasad; C Vardy; C Prasad
Journal:  Paediatr Child Health       Date:  1999-11       Impact factor: 2.253

Review 4.  Variations in prevalence of attention deficit hyperactivity disorder worldwide.

Authors:  Maria Skounti; Anastas Philalithis; Emmanouil Galanakis
Journal:  Eur J Pediatr       Date:  2006-10-11       Impact factor: 3.183

5.  Overcoming challenges in the diagnosis and treatment of attention-deficit/hyperactivity disorder in African Americans.

Authors:  Rahn K Bailey; Dion L Owens
Journal:  J Natl Med Assoc       Date:  2005-10       Impact factor: 1.798

6.  Cardiac risk assessment before the use of stimulant medications in children and youth: A joint position statement by the Canadian Paediatric Society, the Canadian Cardiovascular Society and the Canadian Academy of Child and Adolescent Psychiatry.

Authors:  R Hamilton; C Gray; S A Bélanger; A E Warren; R M Gow; S Sanatani; J-M Côté; J Lougheed; J LeBlanc; S Martin; B Miles; C Mitchell; D A Gorman; M Weiss; R Schachar
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2009-11

Review 7.  Cardiac risk assessment before the use of stimulant medications in children and youth: A joint position statement by the Canadian Paediatric Society, the Canadian Cardiovascular Society, and the Canadian Academy of Child and Adolescent Psychiatry.

Authors:  A E Warren; R M Hamilton; S A Bélanger; C Gray; R M Gow; S Sanatani; J-M Côté; J Lougheed; J LeBlanc; S Martin; B Miles; C Mitchell; D A Gorman; M Weiss; R Schachar
Journal:  Can J Cardiol       Date:  2009-11       Impact factor: 5.223

8.  Effectiveness and safety of a long-acting, once-daily, two-phase release formulation of methylphenidate (Ritalin ® LA) in school children under daily practice conditions.

Authors:  Fabian Haertling; Beate Mueller; Oliver Bilke-Hentsch
Journal:  Atten Defic Hyperact Disord       Date:  2014-10-28

9.  Relationship between ADHD and depression among university students in macedonia.

Authors:  Lidija Sushevska Panevska; Beti Zafirova-Ivanovska; Kristin Vasilevska; Rozalinda Isjanovska; Hadzhihamza Kadri
Journal:  Mater Sociomed       Date:  2015-02-21

10.  Prevalence, gender distribution and presence of attention deficit hyperactivity disorder by certain sociodemographic characteristics among university students.

Authors:  Lidija Sushevska Panevska; Beti Zafirova-Ivanovska; Kristin Vasileva; Rozalinda Isjanovska; Hadzhihamza Kadri
Journal:  Mater Sociomed       Date:  2014-08-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.